Vabysmo is indicated for the treatment of adult patients with: neovascular (wet) age-related macular degeneration (nAMD) (see Pharmacology: Pharmacodynamics under Actions); visual impairment due to diabetic macular oedema (DMO) (see Pharmacology: Pharmacodynamics under Actions).